A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray

Journal of Allergy and Clinical Immunology

Volumn 98, Issue 4, 1996, Pages 724-731

  Graft, David ^a   Aaronson, Donald ^b   Chervinsky, Paul ^c   Kaiser, Harold ^d   Melamed, Julian ^e   Pedinoff, Andrew ^f   Rosen, James P ^g   Schenkel, Eric J ^d   Vandewalker, Mark L ^h   Keim, Andrew ⁱ   Jensen, Peder K ⁱ   Nolop, Keith ⁱ   Mesarina Wicki, Bárbara ⁱ  

^a PARK NICOLLET CLINIC   (United States)

^b Aaronson Asthma and Allerg Assoc   (United States)

^c Allergy and Asthma Center   (United States)

^d Certified Allergy Department ^*

^e Certified Allergy Consultants   (United States)

^f Princeton Allergy and Asthma Associates   (United States)

^g Pediatric Allergy Associates   (United States)

^h Clinical Research of the Ozarks   (United States)

ⁱ MERCK RESEARCH LABORATORIES   (United States)

Author keywords

intranasal corticosteroids; Mometasone furoate; prophylaxis; ragweed; seasonal allergic rhinitis

Indexed keywords

MOMETASONE FUROATE;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0029958150     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70119-7     Document Type: Article

References (26)

1. International Rhinitis Management Working Group. International consensus report on the diagnosis and management of rhinitis. Eur J Allergy Clin Immunol 1994;49:1-34.
2. Meltzer EO. Treating allergic rhinitis. Overview and update. Am J Asthma Allergy Pediatr 1992;6:13-7.
3. Mabry RL. Topical pharmacotherapy for allergic rhinitis: new agents. South Med J 1992;85:149-54.
4. Siegel SC. Topical intranasal corticosteroid therapy in rhinitis. J Allergy Clin Immunol 1988;81:984-91.
5. Brattsand R, Thalen A, Roempke K, Kallstrom L, Gruvstad E. Development of new glucocorticosteroids with a very high ratio between topical and systemic activities. J Steroid Biochem 1982;16:62-73.
6. Naclerio RM. Allergic rhinitis. N Engl J Med 1991;325:860-9.
7. Connell JT. Quantitative intranasal challenges. I. The priming effect and its relationship to histopathological changes in nasal biopsies. J Allergy 1968;41:101-10.
8. Borum P, Gronborg H, Brofeldt S, Mygind N. Nasal reactivity in rhinitis. Eur J Respir Dis 1983;64:65-71.
9. De Weck AL. The role of lymphokines in allergic inflammation. Allergologie 1989;12:85-9.
10. Connell JT. Quantitative intranasal pollen challenge. II. Effect of daily pollen challenge, environmental pollen exposure, and placebo challenge on the nasal membrane. J Allergy 1968;41:123-39.
11. Connell JT. Quantitative intranasal challenges. III. The priming effect in allergic rhinitis. J Allergy 1969;43:33-44.
12. Bousquet J, Hejjaoui A, Becker W, Cour P, Chanal I, Lebel B, et al. Clinical and immunologic reactivity of patients allergic to grass pollens and to multiple pollen species. I. Clinical and immunologic characteristics. J Allergy Clin Immunol 1991;87:737-46.
13. Bousquet J, Chanal I, Alquie MC, et al. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study. Allergy 1993;48:327-33.
14. Viegas M, Gomez E, Brooks J, Gatland D, Davies RJ. Effect of the pollen season on nasal mast cells. Br Med J 1987;294:414-5.
15. Otsuka H, Denburg JA, Befus AD, et al. Effects of beclomethasone dipropionate on nasal metachromatic cell subpopulations. Clin Allergy 1986;16:589-97.
16. Schleimer RP, Kato M, Kaiser J, Lichtenstein LM, Bochner BS, Liu M. Antiinflammatory steroid actions in human lung. In: Holgate ST, Austen KF, Lichtenstein LM, Kay AB, editors. Asthma: physiology, immunopharmacology and treatment. Fourth International Symposium. London: Academic Press, 1993:375-89.
17. Anderson M, Anderson P, Venge P, Pipkorn U. Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced hyperresponsiveness: effects of topical glucocorticoid treatment. Allergy 1989;44:342-8.
18. Bascom R, Wachs M, Naclerio RM, et al. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988;81:580-9.
19. Creticos PS. Allergic rhinitis. In: Busse WW, Holgate ST, editors. Asthma and rhinitis 1995:1394-414.
20. Rosenthal D, Duke E. A clinical investigation of the efficacy and safety of mometasone furoate ointment 0.1% vs. betamethasone valerate ointment 0.1% in the treatment of psoriasis. Curr Ther Res 1988;44:790-801.
21. Bronsky E, Pedinoff A. Nolop K. Dose ranging study of the activity and tolerance of mometasone furoate in seasonal allergic rhinitis [abstract]. Allergy (Suppl) 1995;50:191.
22. Prenner B, Chervinsky P, Hampel FC, Howland WC, Lawrence M, Meltzer EO, et al. Double-strength beclomethasone dipropionate (84 μg/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1996;98:302-8.
23. Nuutinen J, Ruoppi P, Suonpaa J. One-dose beclomethasone dipropionate aerosol in the treatment of seasonal allergic rhinitis. A preliminary report. Rhinology 1987;25:121-7.
24. Ratner P, Findlay S, Greenstein S, Nebesnak C. Beclomethasone dipropionate, 84 meg/spray in the treatment of seasonal allergic rhinitis [abstract]. J Allergy Clin Immunol 1993;91:194.
25. Mann MC, Eliasson O, Patel K, ZuWallack RL. An evaluation of severity-modulated compliance with q.i.d. dosing of inhaled beclomethasone. Chest 1992;102:1342-6.
26. Apter AJ, ZuWallack RL, Clive J. Common measures of asthma severity lack association for describing its clinical course. J Allergy Clin Immunol 1994;94:723-7.